Clark Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Clark Wealth Partners's BMY Position: Q2 2026 in Review
Clark Wealth Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 717 shares worth $41.3K. The position accounts for 0.02% of the portfolio, ranked #128.
Clark Wealth Partners first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $43.5K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Clark Wealth Partners held 717 shares of Bristol-Myers Squibb worth $41.3K as of Q2 2026.
- Clark Wealth Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.02% of Clark Wealth Partners's portfolio in Q2 2026, its #128 holding.
- Clark Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Clark Wealth Partners's Bristol-Myers Squibb position peaked at $43.5K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.